Register: Resilience Through Reinvention: How Pharma is Navigating Uncertainty During Turbulent Times

Date: Tuesday, September 30, 2025 11am–12pm EDT
Event Location: Virtual

Drug development is already complex, but in this regulatory landscape, risks lurk at every turn. Funding decreases, manufacturing uncertainties, loss of regulatory expertise, legal challenges, and the threats of tariffs have elevated risks to both investors and drug and device developers in the United States market. The effects, however, go beyond the United States, as the global market pivots and tries to adapt to each move the United States makes. While many of these changes are new, our guests give their observations and recommendations on how to move forward.

Key Takeaways

• Understanding the global impact on the United States market’s reduced funding.
• International funding and investment opportunities beyond U.S. markets
• The complications surrounding current manufacturing initiatives.
• Other countries’ efforts to establish themselves as viable clinical trial locations.
• How companies are navigating the environment.

Dr. Khanh Courtney

Biologics Technical Strategy Leader | Element Materials Technology

Dr. Khanh Courtney specializes in solving complex analytical challenges for biopharmaceutical products through expert method development and stage-appropriate validation. Drawing on her Ph.D. in biochemistry from the University of Wisconsin-Madison, she excels at designing characterization studies that address critical regulatory requirements and creating robust documentation for IND/BLA applications. Her technical expertise bridges the gap between R&D innovation and CMC compliance, enabling smoother regulatory pathways for biological therapeutics.

Ali Pashazadeh

CEO | Treehill Partners

Ali Pashazadeh is founder and CEO of Treehill Partners. He has 20 years experience at Goldman Sachs, UBS and Blackstone as a healthcare investment banker, advising companies on large, complex, global strategic transactions. He also has 30 years ongoing experience as a trauma and reconstructive surgeon, and as a biotech CEO.

Mike Walker

VP for Life Sciences Advisory | Microsoft

Mike J. Walker is a VP for Life Sciences Advisory at Microsoft that is known as an industry authority on emerging technologies & digital innovation. He’s a 30-year digital-transformation expert that inspires leaders in areas like agentic AI, IoT, digital twins, cybersecurity, and more.

Lori Ellis

Head of Insights | BioSpace

Lori is the head of insights at BioSpace. She analyzes and comments on industry trends for BioSpace and clients. She creates engaging content for clients to support their marketing objectives. She has been part of an award-winning marketing team and has won a Muse Creative award, a Vega award and several Adobe awards in collaborative team projects for her audio narration work. Her experience in the television/film and audio industries benefits both BioSpace and partners through her moderation and hosting of live and virtual events. While she has covered all elements of the drug development process, her primary focuses are women’s health issues, the economic climate, and the ever-evolving impact of technology – specifically artificial intelligence – on the pharmaceutical industry.